XML 66 R55.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Contingencies - Patent Litigation - Narrative (Details) - USD ($) $ in Millions | 1 Months Ended | 36 Months Ended | 84 Months Ended
--- | --- | --- | ---
Jan. 31, 2017 | Dec. 31, 2016 | Mar. 31, 2016 | Dec. 31, 2026 | Dec. 31, 2023
Anti-PD-1 Antibody Patent Case |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Payment under settlement and license agreement | $ 625 |  |  |  |
Anti-PD-1 Antibody Patent Case | Forecast |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Royalty rate (as percent) |  |  |  | 2.50% | 6.50%
Gilead Patent Case |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Percentage of settlement to be paid to third-party (as percent) |  |  | 20.00% |  |
Amount awarded to company |  | $ 2,540 | $ 200 |  |

X
- Definition Percentage of settlement to be paid to third-party. + References No definition available. + Details
Name: | mrk_Percentageofsettlementtobepaidtothirdparty
Namespace Prefix: | mrk_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty rate + References No definition available. + Details
Name: | mrk_RoyaltyRate
Namespace Prefix: | mrk_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount awarded from other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedFromOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3536-108585 + Details
Name: | us-gaap_PaymentsForLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_LitigationCaseAxis=mrk_AntiPD1AntibodyPatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationCaseAxis=mrk_GileadPatentCaseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |